Latest Research in Lipoproteins and Cardiovascular Health
42 research papers · 2026 median publication year
Top Research Topics in Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health — 21 papers
- Diabetes, Cardiovascular Risks, and Lipoproteins — 5 papers
- Cardiovascular Health and Disease Prevention — 3 papers
- Adipokines, Inflammation, and Metabolic Diseases — 2 papers
- Atherosclerosis and Cardiovascular Diseases — 1 papers
- Advanced Proteomics Techniques and Applications — 1 papers
- Cardiovascular Disease and Adiposity — 1 papers
- Gout, Hyperuricemia, Uric Acid — 1 papers
- Mitochondrial Function and Pathology — 1 papers
- Folate and B Vitamins Research — 1 papers
Highest-Cited Papers
- A Practical Approach to Elevated Lipoprotein(a): Is There a Role for Nutraceuticals in Clinical Practice?
- A Practical Approach to Elevated Lipoprotein(a): Is There a Role for Nutraceuticals in Clinical Practice?
- Sex differences in the associations of body composition and PPARGC1A genetic variants with elevated pulse pressure
- Monitoring strategies in adults eligible for pharmacological lipid-lowering therapy
- Oral PCSK9 inhibitors: closing the gap between potency and practicality
- A structural cardiac pathway mediates the risk of ischemic heart disease from TyG-related indices: A prospective cohort study
- Sex-specific proteomic risk scores reveal distinct cardiovascular risk profiles and improve prediction of major adverse cardiovascular events in hypertension
- A Practical Approach to Elevated Lipoprotein(a): Is There a Role for Nutraceuticals in Clinical Practice?
- Heterogeneity in Lipoprotein(a) Profile Changes Across the Menopausal Transition
- Chemerin and Arterial Stiffness in the Brisighella Heart Study: A Residual-Based Discordance Analysis
- Prognostic value of epicardial and pericardial adipose tissue in patients with chronic heart failure
- LIPOPROTEIN(A): A GENETICALLY DETERMINED RISK MARKER IN TYPE 2 DIABETES AND OBESITY
- HDL Cholesterol: A Fifty-Year Journey
- LIPOPROTEIN(A): A GENETICALLY DETERMINED RISK MARKER IN TYPE 2 DIABETES AND OBESITY
- Long-term triglyceride glucose index (TyG)-uric acid burden and incident stroke in the China Health and Retirement Longitudinal Study (CHARLS): repeated-exposure and transition analyses
- Interpreting the role of lipoprotein(a) in metabolic disorders: current evidence and future perspectives
- Formula-dependent LDL-C threshold classification and reporting uncertainty in the UK Biobank
- Association of the TyHGB index with incident stroke in middle-aged and older Chinese adults: a 10-year prospective cohort study
- PLTP Variants rs6065904 and rs378114 Are Associated with Acute Coronary Syndrome Risk and Altered Glucose and Triglyceride Levels in a Mexican Population
- Evaluating enlicitide decanoate: first oral PCSK9 inhibitor for the treatment of adults with hypercholesterolemia